Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Special Issue

KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease

Mi Na Kim, Ji Won Han, Jihyun An, Beom Kyung Kim, Young-Joo Jin, Seung-seob Kim, Minjong Lee, Han Ah Lee, Yuri Cho, Hee Yeon Kim, Yu Rim Shin, Jung Hwan Yu, Moon Young Kim, YoungRok Choi, Young Eun Chon, Eun Ju Cho, Eun Joo Lee, Sang Gyune Kim, Won Kim, Dae Won Jun, Seung Up Kim

Clin Mol Hepatol. 2024;30(suppl):s5-s105. Published online August 19, 2024

DOI: https://doi.org/10.3350/cmh.2024.0506

PDF

View: 564 Download: 87

Original Article

Comparison of four histological scoring systems for autoimmune hepatitis to improve diagnostic sensitivity

Soomin Ahn, Sook-Hyang Jeong, Eun Ju Cho, Kyoungbun Lee, Gilhyang Kim, Haeryoung Kim

Clin Mol Hepatol. 2024;30(1):37-48. Published online November 13, 2023

DOI: https://doi.org/10.3350/cmh.2023.0325

View: 2764 Download: 190 Web of Science: 1 Crossref: 3

Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection

Jeongin Yoo, Heejin Cho, Dong Ho Lee, Eun Ju Cho, Ijin Joo, Sun Kyung Jeon

Clin Mol Hepatol. 2023;29(4):1029-1042. Published online August 29, 2023

DOI: https://doi.org/10.3350/cmh.2023.0190

View: 3263 Download: 141 Web of Science: 1

Inhibition of PI3K/Akt signaling suppresses epithelial-to-mesenchymal transition in hepatocellular carcinoma through the Snail/GSK-3/beta-catenin pathway

Seulki Lee, Eun Ji Choi, Eun Ju Cho, Yun Bin Lee, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim

Clin Mol Hepatol. 2020;26(4):529-539. Published online August 24, 2020

DOI: https://doi.org/10.3350/cmh.2019.0056n

View: 8642 Download: 253 Web of Science: 31 Crossref: 32

Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment

Cheol-Hyung Lee, Yun Bin Lee, Minseok Albert Kim, Heejoon Jang, Hyunwoo Oh, Sun Woong Kim, Eun Ju Cho, Kyung-Hun Lee, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Tae-You Kim, Yoon Jun Kim

Clin Mol Hepatol. 2020;26(3):328-339. Published online May 28, 2020

DOI: https://doi.org/10.3350/cmh.2019.0049n

View: 9015 Download: 344 Web of Science: 33 Crossref: 32

Review

Current status and strategies for viral hepatitis control in Korea

Dong Hyun Sinn, Eun Ju Cho, Ji Hoon Kim, Do Young Kim, Yoon Jun Kim, Moon Seok Choi

Clin Mol Hepatol. 2017;23(3):189-195. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0033

View: 9072 Download: 244 Web of Science: 20 Crossref: 22

Current status and strategies for hepatitis B control in Korea

Eun Ju Cho, Sung Eun Kim, Ki Tae Suk, Jihyun An, Soung Won Jeong, Woo Jin Chung, Yoon Jun Kim

Clin Mol Hepatol. 2017;23(3):205-211. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0104

View: 13283 Download: 313 Web of Science: 85 Crossref: 85

Original Article

Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients

Goh Eun Chung, Eun Ju Cho, Jeong-Hoon Lee, Jeong-ju Yoo, Minjong Lee, Yuri Cho, Dong Hyeon Lee, Hwi Young Kim, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Fabien Zoulim

Clin Mol Hepatol. 2017;23(1):66-73. Published online February 14, 2017

DOI: https://doi.org/10.3350/cmh.2016.0060

View: 10348 Download: 167 Web of Science: 12 Crossref: 11

Case Report

Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases

Hyeki Cho, Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Kook-Hwan Oh, Kyoungbun Lee, Syifa Mustika, Jung-Hwan Yoon, Yoon Jun Kim

Clin Mol Hepatol. 2016;22(2):286-291. Published online June 25, 2016

DOI: https://doi.org/10.3350/cmh.2015.0066

View: 10723 Download: 175 Web of Science: 11 Crossref: 13

Original Article

Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea

Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim

Clin Mol Hepatol. 2015;21(4):358-364. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.358

View: 8642 Download: 105 Web of Science: 12 Crossref: 11

Retrospective analysis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome in Korea: characteristics, treatments, and outcomes

Yoonsang Park, Yuri Cho, Eun Ju Cho, Yoon Jun Kim

Clin Mol Hepatol. 2015;21(2):150-157. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.150

View: 11008 Download: 165 Web of Science: 19 Crossref: 20

Hepatitis C virus (HCV) genotypes and the influence of HCV subtype 1b on the progression of chronic hepatitis C in Korea: a single center experience

Eun Ju Cho, Su Hyeon Jeong, Byung Hoon Han, Sang Uk Lee, Byung Chul Yun, Eun Taek Park

Clin Mol Hepatol. 2012;18(2):219-224. Published online June 26, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.2.219

View: 7652 Download: 58 Crossref: 24

Validation of P2/MS for reflecting hepatic fibrosis in patients with hepatocellular carcinoma

Su Jong Yu, Jeong-Hoon Lee, Goh Eun Chung, Chang-Hoon Lee, Eun Ju Cho, Eun Sun Jang, Min-Sun Kwak, Yoon Jun Kim, Jung-Hwan Yoon, Ja-June Jang, Hyo-Suk Lee

Clin Mol Hepatol. 2010;16(4):389-396. Published online December 31, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.4.389

View: 7762 Download: 55 Crossref: 1

Editorial

Elimination of viral hepatitis: How far are we?

Eun Ju Cho

Received July 12, 2024 Accepted July 20, 2024

DOI: https://doi.org/10.3350/cmh.2024.0557 [Accepted]

PDF

View: 289 Download: 12

Viewed By 5106	MAFLD: How is it different from NAFLD?
Viewed By 4872	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4871	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4560	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4534	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 219	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 155	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 134	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 119	MAFLD: How is it different from NAFLD?
Cited By 96	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Author :

Author index